Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF32 antisense RNA 1 (ZNF32-AS1) is a long non-coding RNA (lncRNA) located on human chromosome 17, also known by aliases including ZNF32OS1 and bA402L1.8[1][2][4]. It does not code for a protein but is thought to play a regulatory role in cellular processes, particularly by modulating gene expression[1][3]. ZNF32-AS1 is classified as an antisense RNA because it is transcribed from the DNA strand opposite the protein-coding ZNF32 gene[1]. Emerging evidence indicates that dysregulation of ZNF32-AS1 occurs in various cancers, suggesting a possible role in tumorigenesis, though its precise biological functions and mechanisms remain unclear[1][2][3]. There are currently no known drugs, biomarker roles, or established safety concerns directly linked to ZNF32-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF32 antisense RNA 1 (ZNF32-AS1).